These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4307883)

  • 1. Yellow fever vaccine. II. Antigenicity and neurovirulence of a vaccine seed free from avian leukosis virus.
    Tauraso NM; Spector SL; Kirschstein RL; Seligmann EB; Farber JF
    Appl Microbiol; 1969 Jun; 17(6):866-70. PubMed ID: 4307883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yellow fever vaccine. I. Development of a vaccine seed free from contaminating avian leukosis viruses.
    Tauraso NM; Spector SL; Jahnes WG; Shelokov A
    Proc Soc Exp Biol Med; 1968 Apr; 127(4):1116-20. PubMed ID: 4297696
    [No Abstract]   [Full Text] [Related]  

  • 3. Yellow fever vaccine. IV. Reactogenicity and antibody response in volunteers inoculated with a vaccine free from contaminating avian leukosis viruses.
    Tauraso NM; Coultrip RL; Legters LJ; Richman AV; Rosenberg DM; Savadge TO; Shelokov A; Spector SL; Trimmer RW
    Proc Soc Exp Biol Med; 1972 Feb; 139(2):439-46. PubMed ID: 4333781
    [No Abstract]   [Full Text] [Related]  

  • 4. Yellow fever vaccine. 3. Antibody response in monkeys inoculated with a vaccine free from contaminating avian leukosis viruses.
    Tauraso NM; Spector SL; Trimmer RW
    Arch Gesamte Virusforsch; 1972; 37(2):211-7. PubMed ID: 4337545
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
    Guirakhoo F; Zhang Z; Myers G; Johnson BW; Pugachev K; Nichols R; Brown N; Levenbook I; Draper K; Cyrek S; Lang J; Fournier C; Barrere B; Delagrave S; Monath TP
    J Virol; 2004 Sep; 78(18):9998-10008. PubMed ID: 15331733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-dependent enhancement of yellow fever and Japanese encephalitis virus neurovirulence.
    Gould EA; Buckley A
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1605-8. PubMed ID: 2543793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurovirulence, viscerotropism and immunogenicity of live attenuated yellow fever 17D vaccine virus in non-human primates.
    Tyagi P; Ganguly M; Manney S; Wadkar K; Ingle N; Gairola S; Dhere R; Koide F; Grimes S
    Vaccine; 2023 Jan; 41(3):836-843. PubMed ID: 36564277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHO working group meeting to amend WHO Recommendations to assure the quality, safety and efficacy of live attenuated yellow fever vaccines.
    Martin J; Barrett ADT; Lei D; Minor P
    Vaccine; 2022 Jun; 40(26):3490-3494. PubMed ID: 35550848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys.
    Marchevsky RS; Freire MS; Coutinho ES; Galler R
    Virology; 2003 Nov; 316(1):55-63. PubMed ID: 14599790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.
    Monath TP; Myers GA; Beck RA; Knauber M; Scappaticci K; Pullano T; Archambault WT; Catalan J; Miller C; Zhang ZX; Shin S; Pugachev K; Draper K; Levenbook IS; Guirakhoo F
    Biologicals; 2005 Sep; 33(3):131-44. PubMed ID: 15975826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurovirulence tests of three 17D yellow fever vaccine strains.
    Minor PD
    Biologicals; 2011 May; 39(3):167-70. PubMed ID: 21536454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ontogeny of yellow fever 17D vaccine: RNA oligonucleotide fingerprint and monoclonal antibody analyses of vaccines produced world-wide.
    Monath TP; Kinney RM; Schlesinger JJ; Brandriss MW; Brès P
    J Gen Virol; 1983 Mar; 64 Pt 3():627-37. PubMed ID: 6298349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A yellow fever vaccine free from avian leucosis viruses.
    Draper CC
    J Hyg (Lond); 1967 Dec; 65(4):505-13. PubMed ID: 4383742
    [No Abstract]   [Full Text] [Related]  

  • 15. Avian leukosis antibody response in individuals given chicken embryo derived vaccines.
    Richman AV; Aulisio CG; Jahnes WG; Tauraso NM
    Proc Soc Exp Biol Med; 1972 Jan; 139(1):235-7. PubMed ID: 4332330
    [No Abstract]   [Full Text] [Related]  

  • 16. Serological reactions in Rhesus monkeys inoculated with the 17D strain of yellow fever virus.
    GROOT H
    Bull World Health Organ; 1962; 27(6):709-15. PubMed ID: 13950709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yellow fever vaccine. V. Antibody response in maonkeys inoculated with graded doses of the 17D vaccine.
    Mason RA; Tauraso NM; Ginn RK; O'Brien TC; Trimmer RW
    Appl Microbiol; 1972 May; 23(5):908-13. PubMed ID: 4624211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
    Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
    Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models.
    Piras-Douce F; Raynal F; Raquin A; Girerd-Chambaz Y; Gautheron S; Sanchez MEN; Vangelisti M; Mantel N
    Vaccine; 2021 Mar; 39(13):1846-1856. PubMed ID: 33685778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.